Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02548598 · ClinicalTrials.gov registry record
Analysis of Inflammation and Microbiome in Patients With Sinusitis and Asthma
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 9
- Enrollment target
NCT02548598: Completed study, sponsored by University of California, San Francisco.
NCT02548598 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02548598 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This is a cross-sectional, non-interventional study, consisting of three study arms, (1) Full Characterization (AIMS-Full), (2) Surgery Arm (AIMS-OR), and (3) Mucus Collection (AIMS-M). Participants will be recruited and enrolled in either AIMS-Full or AIMS-OR (based on participant availability). Participants who complete the initial characterization study (either AIMS-Full or AIMS-OR), may also go on to participate in the AIMS-M arm, which focuses mainly on sample collection. Participants who choose not to participate in either characterization arm are able to enroll directly into AIMS-M for sample collection only.
Primary Outcome
This study enrolls participants with and without asthma with concomitant chronic rhinosinusitis (CRS). Investigators aim to study severity of CRS among the two groups following endoscopic sinus surgery. Severity of CRS will be judged using the Sino-Nasal Outcome Test-22, a paper-based, validated questionnaire.
Interventions
- PROCEDURE Endoscopic sinus surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-01 |
| Est. Completion | 2021-04 |
What the finished NCT02548598 record still lists
NCT02548598 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic sinus surgery is the first listed.
NCT02548598 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02548598 about?
NCT02548598 is a clinical study titled "Analysis of Inflammation and Microbiome in Patients With Sinusitis and Asthma". This is a cross-sectional, non-interventional study, consisting of three study arms, (1) Full Characterization (AIMS-Full), (2) Surgery Arm (AIMS-OR), and (3) Mucus Collection (AIMS-M). Participants will be recruited and enrolled in either AIMS-Full or AIMS-OR (based on participant availability). Pa...
What is the current status of trial NCT02548598?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2017-01. Estimated completion is 2021-04.
What interventions are being tested in trial NCT02548598?
The interventions under investigation include: Endoscopic sinus surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02548598?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia